One Health Day, celebrated each November 3, highlights the important connections between human, animal, and environmental health. At VetStem, this connection is part of our history. Since 2002, VetStem has helped advance regenerative medicine in veterinary patients, building experience in processing and using a patient’s own stem cells. That foundation ultimately helped pave the way for Personalized Stem Cells (PSC), bringing the potential of regenerative medicine to human patients.

Through PSC, patients can access cell banking services, allowing them to store their own cells for potential future use, as well as investigational treatment options through its Right to Try program for eligible patients with serious or life-threatening conditions. By building on the experience gained through veterinary regenerative medicine, PSC is working to expand opportunities for patients while continuing to explore the potential of their own cells.

PSC has also participated in human clinical research, including studies involving knee osteoarthritis and COVID-19. Now, PSC is advancing this work through a newly approved FDA clinical trial investigating stem cell therapy for traumatic brain injury (TBI). This research represents another step in exploring how a patient’s own cells may have a role in addressing challenging medical conditions.

VetStem’s journey illustrates the One Health principle in action: advances in animal health can help inform and inspire new approaches to human medicine. As research continues across both fields, VetStem and PSC remain part of a broader effort to explore the potential of regenerative medicine for the benefit of animals and people alike.